NAD+ Precursor Chews for a Dog Whose Energy Dropped Around Age 8
Medically reviewed by Tamara Shearer, DVM, MSTCVM, CCRP, CVPP, CVA, CHPV, CTPEP —
If your dog's energy dropped around age 8, NAD+ precursor chews are one option worth understanding first.
On this page
Rule Out the Ordinary Before You Reach for a Chew
A dog who slows down at 8 is telling you something, and the first job is finding out what. Energy that fades over a season is rarely one clean problem. Osteoarthritis makes a dog trade the stairs for the couch. An underactive thyroid flattens drive and dulls the coat. Heart disease, anemia, dental pain, and early cognitive change all read as “less pep” from across the room, and none of them is fixed by a supplement. Some are genuinely treatable. So book the exam first. Ask for a physical, bloodwork, and a thyroid panel, and describe the change in plain terms — shorter walks, later mornings, less interest in the ball. A NAD+ precursor chew earns a place in the conversation only after the treatable causes are off the table.
What a NAD+ Precursor Is, and What It Is Not
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme every cell uses to turn food into usable energy and to run its repair machinery. Its levels fall with age across many tissues, which is the reasoning behind this whole category. A precursor is simply a raw material the body converts into NAD+. The two you will meet on labels — nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) — are close relatives of vitamin B3; the NIH Office of Dietary Supplements groups NR among the niacin-related compounds the body turns into NAD+. In people, that conversion is real and measurable. Single oral doses of 100, 300, and 1,000 mg of NR produced dose-dependent increases in the blood NAD+ metabolome, and 1,000 mg a day for six weeks was well tolerated while raising NAD+ in adults aged 55 to 79. A precursor chew, then, is a way to supply that raw material. It is not a stimulant, and it does not deliver energy the way a meal or a nap does.
The Dog Evidence: Clear on Cognition, Quiet on Energy
Here is the honest part, and for a dog whose get-up-and-go has faded it matters most. The best canine trial to date randomized 70 dogs aged 10 and older with mild-to-moderate cognitive decline to placebo, a low dose, or a full dose of a combined senolytic and NAD+ precursor. Over three months, the full-dose group showed a significant improvement in owner-rated cognitive scores (p = 0.02). On the objective wearable activity monitors, though, there was no significant difference between groups, and in-house cognitive testing did not separate them either. Put plainly: the measurable activity needle did not move, even as the owner-scored cognition did. That is a useful boundary to hold. The current canine data supports a cognition signal more than an energy one, and a chew sold for “vitality” is leaning on human NAD+ biology plus owner impressions, not on a proven canine energy effect.
NR Versus NMN, and How to Read the Rest of the Label
Once you have decided to try one, read the label like a spec sheet. Look for the precursor named outright with a per-serving dose in milligrams — not a “proprietary blend” that hides the amount. Prefer NR for a regulatory reason: the FDA ruled in late 2022 that NMN may not be legally sold as a dietary supplement, because it had been accepted for investigation as a drug, so an NMN chew stands on weaker ground than an NR one. Check for the NASC Quality Seal, which signals the maker passed an independent third-party audit and reports adverse events. Then ask the company for a certificate of analysis — a batch-level lab test confirming the chew holds what the label claims and screening for contaminants. A brand that will not share one has answered the question for you.
A Single Chew Versus a Whole-Dog Recovery Plan
Treat the chew as one input, not the plan. An 8-year-old’s energy lives or dies on the unglamorous fundamentals: a lean body weight that spares the joints, consistent low-impact movement, honest recovery windows between harder days, and pain that is actually controlled. If arthritis is the reason a dog quit the stairs, the highest-yield move is a vet-guided pain and mobility plan, and any longevity chew rides on top of that rather than standing in for it. Keep the goal comfort-first and modest: a NAD+ precursor may help support cellular energy metabolism at the margins, while the daily load you manage does the real work for how your dog feels.
Bottom line: for a dog whose energy dropped after 8, a NAD+ precursor chew is a reasonable, low-risk thing to try once a veterinarian has cleared the treatable causes — but buy it for the cellular-health rationale and honest expectations, not for a canine energy boost the evidence has not yet shown.
Frequently asked questions
My dog's energy dropped at 8 — will a NAD+ precursor chew fix it?
Not on its own, and not before a vet visit. A fading engine at 8 is often driven by arthritis pain, low thyroid, dental disease, or a heart or blood problem — treatable things a chew does nothing for. Rule those out first with an exam, bloodwork, and a thyroid panel. A precursor chew is a reasonable add-on once the treatable causes are cleared, with modest expectations.
Should I look for NR or NMN on the label?
Nicotinamide riboside (NR) is the safer regulatory choice. In late 2022 the FDA ruled that NMN may not be legally sold as a dietary supplement because it had been accepted for investigation as a drug, so an NMN product sits on shakier ground than an NR one. Both are NAD+ precursors related to vitamin B3, but only NR is on solid supplement footing.
How long before I would notice anything?
In the main canine trial, owner-rated cognitive scores improved over about three months on the full dose. Objective activity monitors, though, showed no significant change — so the honest answer is give any trial several weeks, judge it against clear before-and-after notes you write down, and do not expect a visible energy surge the data has not shown.
Are these chews safe for a senior dog?
In the 70-dog trial the combination was well tolerated, with mild side effects spread equally across the placebo and treatment groups. That is reassuring, not a guarantee. Clear any new supplement with your veterinarian first, especially if your dog takes other medications, since interactions and dosing are a clinical call.
Sources
- A randomized, controlled clinical trial demonstrates improved owner-assessed cognitive function in senior dogs receiving a senolytic and NAD+ precursor combination — Scientific Reports (Nature), 2024
- Nicotinamide riboside is uniquely and orally bioavailable in mice and humans — Nature Communications, 2016 (Trammell et al.)
- Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults — Nature Communications, 2018 (Martens et al.)
- Niacin: Fact Sheet for Health Professionals — NIH Office of Dietary Supplements
- NASC Quality Seal — National Animal Supplement Council